Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Martens AWJ, Janssen SR, Derks IAM, et al. CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells. J Immunother Cancer 2020;8:e000218. doi: 10.1136/jitc-2019-000218
This paper has been updated since first published to update Figure 5I. One patient was removed from the figure since the patient originally labeled as chronic lymphocytic leukemia, has been recently re-diagnosed as indolent CD5 +mantle cell lymphoma.